Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance

Bibliographic Details
Main Authors:	Johnathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, Gladice Wallraven, Ernest Bognar, Laura Stanbery, Staci Horvath, Meghan Manley, John Nemunaitis, Adam Walter, Rodney P. Rocconi
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	Gynecologic Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352578920301144

Internet